Bloomberg
When a Miracle Cure Is Left on the Shelf
Once hailed as the future of medicine, gene therapies are losing the confidence of pharma giants and investors as costs mount and commercial returns disappoint.
October 2024 · 14 min read
Bloomberg
Once hailed as the future of medicine, gene therapies are losing the confidence of pharma giants and investors as costs mount and commercial returns disappoint.
October 2024 · 14 min read
Bloomberg
As vaccine skepticism reaches the highest levels of U.S. health policy, anxious parents are pressing pediatricians to move up their children's immunizations.
July 2025 · 15 min read
Bloomberg
Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.
May 2026 · 20 min read
Bloomberg
As baby boomers age into greater medical need, a strained workforce of doctors, nurses and aides faces a widening gap that threatens patient care.
August 2023 · 8 min read
Bloomberg
Drugmakers have delivered long-promised one-shot cures — but a thin pipeline of eligible patients is forcing a hard rethink of the gene therapy business.
February 2024 · 16 min read
Bloomberg
As Leqembi rolls out to patients, a small but troubling number of deaths is forcing doctors to confront harder questions about who should — and shouldn't — receive the drug.
March 2025 · 22 min read
Bloomberg
Moderna bet its mRNA platform could leapfrog rivals in the race to protect older adults from RSV. The data tell a more complicated story.
May 2024 · 16 min read
Bloomberg
A new class of painkillers promises relief without the risk of addiction. The catch: pricing that could put them out of reach for the patients who need them most.
July 2024 · 12 min read
Bloomberg
As million-dollar gene therapies reach the market, some employers are drawing a hard line — leaving workers and their families to fight for access to treatments that could save their lives.
September 2024 · 18 min read
Bloomberg
A former NFL punter turned podcaster parlays an unconventional media playbook — and a massive FanDuel pact — into a perch at the center of football culture.
January 2022 · 10 min read